SCHEDULE: Franklin Resources Divests Adverum Biotech Stake

Franklin Resources, Inc. and its principals have reported a 0% beneficial ownership in Adverum Biotechnologies, Inc., indicating a full divestment of their previously held stake.

Summary

• Franklin Resources, Inc., along with Charles B. Johnson and Rupert H. Johnson, Jr., filed an Amendment No. 1 to Schedule 13G for Adverum Biotechnologies, Inc.
• The filing reports 0.0% beneficial ownership of Adverum Biotechnologies, Inc.'s Common Stock, $0.0001 par value, by all reporting persons.
• This indicates that the reporting persons no longer hold a reportable beneficial ownership stake in Adverum Biotechnologies, Inc.
• The CUSIP number for the securities is 00773U207.
• The date of the event requiring this filing was June 30, 2025, with the statement signed on August 1, 2025.

Sentiment

Score: 3

Explanation: The filing indicates a complete divestment of beneficial ownership by Franklin Resources, Inc. and its principals, which is generally perceived as a negative signal for the issuer as an institutional investor has exited their position.

Negatives

• The complete divestment of beneficial ownership by Franklin Resources, Inc. and its principals could be perceived negatively by the market, as a significant institutional investor has exited their position.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a change in beneficial ownership by an institutional investor. It does not provide specific insights into broader industry trends but reflects a portfolio adjustment by a major asset manager.

Stakeholder Impact

• Shareholders of Adverum Biotechnologies, Inc. may view the divestment by Franklin Resources, Inc. as a negative signal, potentially impacting investor confidence.

Key Dates

Keywords

Adverum Biotechnologies, Franklin Resources, SEC filing, Schedule 13G, beneficial ownership, divestment, common stock, biotechnology